| 摘要 |
PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein- cholesterol and to lower certain other plasma lipid levels, such as LDL- cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL- cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans.
|
